TrialNet Type 1 Diabetes Pathway to Prevention Study
Pathway to Prevention of Type 1 Diabetes (T1D)- Pediatrics
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Enrolling: Male and Female Patients
IRB Number: AAAA3272
U.S. Govt. ID: NCT00097292
Contact: Anabel Evans: / ae2816@cumc.columbia.edu
Additional Study Information: A future without Type 1 Diabetes (T1D) starts with you. Get screened! Thanks in large part to T1D family members, we understand T1D as a disease that progresses in three distinct stages. This new definition in conjunction with TrialNet's Pathway to Prevention screening, allows for earlier detection and intervention.
Investigator
Robin Goland, MD
Do You Qualify?
Is your child 2.5 to 17 years old with a family member with type 1 diabetes? Yes No
Has your child been diagnosed with diabetes? Yes No
Does your child have a previous history of being treated with insulin or oral diabetes medications? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Anabel Evans
ae2816@cumc.columbia.edu

This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE